Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: This aims to evaluate the effects of lamivudine (LAM) and entecavir (ETV) in preventing hepatitis B virus (HBV) re-infection after liver transplantation (LT).
Methods: A retrospective matched case-control method was used in this study. From June 2005 to May 2007, the patients who received LAM (100 mg qd) or ETV (0.5 mg qd) were chosen. The LAM and ETV groups were matched using a 3:1 ratio based on the factors, such as age, gender, LAM or ETV antiviral duration, primary disease, and HBV DNA levels at the initiation of antiviral therapy. Data on serum HBV markers, HBV DNA, and cumulative recurrence were collected.
Results: Two hundred and fifty-two patients were enrolled. The average duration of follow-up was 38.5 and 41.2 months (LAM and ETV groups) (p>0.05). Duration of pre-operative antiviral therapy was 30.3 and 25.8 d (LAM and ETV groups) (p>0.05). The HBV DNA level decreased from 3.89×10(6) to 5.31×10(5) copies/mL before LT in the LAM group, and decreased from 8.74×10(6) to 5.49×10(4) copies/mL in the ETV group (p<0.05). Eighteen patients in LAM group developed HBV re-infection and 0 in ETV group.
Conclusion: ETV is superior to LAM for preventing HBV re-infection following LT.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1399-0012.2011.01448.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Analysis of HBV resistance mutations in treatment of chronic hepatitis B with entecavir and lamivudine].
Zhonghua Yu Fang Yi Xue Za Zhi
August 2025
Department of Clinical Laboratory, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
To analyze Hepatitis B virus(HBV)drug resistance mutations in patients with chronic hepatitis B(CHB)infection who have undergone long-term monotherapy with Entecavir(ETV)and those receiving combination therapy with ETV and Lamivudine(LAM), and to explore the related factors affecting HBV drug resistance mutations. The study retrospectively analyzed patients with CHB, compensated cirrhosis, decompensated cirrhosis, and liver cancer who received long-term nucleotide analogue antiviral therapy at the Fifth Medical Center of PLA General Hospital from August 2012 to August 2019.The patients were divided into an ETV monotherapy group and a combined LAM+ETV therapy group.
View Article and Find Full Text PDFIntraoperative Malfunction of Neuroendoscopic Biopsy Forceps: A Case Report With Technical Note.
Oper Neurosurg
July 2025
Department of Neurological Surgery, Division of Pediatric Neurosurgery, Ann & Robert H. Lurie Children's Hospital, Northwestern University Feinberg School of Medicine, Chicago , Illinois , USA.
Background And Importance: Pineal region tumors often present with symptoms of hydrocephalus, due to obstruction of cerebrospinal fluid outflow at the cerebral aqueduct. A commonly used option for neurosurgical management involves endoscopic third ventriculostomy with concurrent biopsy of the pineal lesion for both diagnostic and management purposes. This can be performed with 1 or 2 trajectories of a rigid endoscope or through a single burr hole with a flexible neuroendoscope.
View Article and Find Full Text PDFNucleoside reverse transcriptase inhibitors (NRTIs) and platinum-based chemotherapeutics are widely utilized in cancer treatment. Evidence suggests that drug plasma concentrations are closely linked to both therapeutic efficacy and the risk of adverse effects. Consequently, developing therapeutic drug monitoring (TDM) methods is essential.
View Article and Find Full Text PDFEffect of switching from prior Nucleos(t)ide Analogue(s) to Tenofovir alafenamide on lipid profile and cardiovascular risk in patients with Chronic Hepatitis B.
PLoS One
May 2025
Gastroenterology and Hepatology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand.
Introduction: Tenofovir alafenamide (TAF) is recommended for chronic hepatitis B (CHB) treatment in international guidelines according to its efficacy and safety. However, in phase III study, an increased LDL-c was observed in those who were switched from Tenofovir disoproxil fumarate (TDF) to TAF. Limited data exists on whether lipid profiles change only in individuals who switched to TAF from TDF or from any nucleoside/nucleotide analogues (NUC).
View Article and Find Full Text PDFA synthesized view of the CSF-blood barrier and its surgical implications for aging disorders.
Front Aging Neurosci
February 2025
Department of Neurosurgery, University of Minnesota, Minneapolis, MN, United States.
In this review, we explore the mechanisms of the blood-cerebrospinal fluid (CSF) barrier and CSF transport. We briefly review the mathematical framework for CSF transport as described by a set of well-studied partial differential equations. Moreover, we describe the major contributors of CSF flow through both diffusive and convective forces beginning at the molecular level and extending into macroscopic clinical observations.
View Article and Find Full Text PDF